This report provides exclusive insights into the COVID-19 impact on the Immuno Oncology Assays Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Immuno Oncology Assays Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Immuno Oncology Assays Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
immuno oncology assays market provides an in-depth analysis of segments and
sub-segments in the global as well as regional immuno oncology assays market.
The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional immuno oncology assays market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global immuno oncology assays market.
According to the report, the global immuno oncology assays market is projected
to grow at a CAGR of 8.6% over the forecast period of 2019-2025.
Immuno oncology is an area of medical research, which
investigate how a body’s own immune system can fight cancer. Immuno oncology
assay helps to determine the patient cancer condition during the cancer
treatment. Further, it helps to determine the patient’s suitability to
immunotherapy. These tests help to stimulate the immune system to treat cancer
and enhance the immune of the body to combat cancer. As per the World Health
Organization’s estimation, 9.6 million people died worldwide in 2018. It cost
around USD 1.16 trillion to the global economy. Around 30-50% of cancers can be
prevented with the help of better testing and treatment of the patients. Cancer
is the second leading cause of death globally. As per the World Health
Organization’s estimation, around 70% of death from cancer occur in low and
middle-income countries. Further, the most common form of cancers in 2018 were
lung (2.9 million cases), breast (2.09 million cases), colorectal (1.80 million
cases), prostate (1.28 million cases), skin cancer (non-melanoma, 1.04 million
cases) and stomach (1.03 million cases). Additionally, these cancerous diseases
were the major common causes of cancer death around the world in 2018. The
early diagnosis of cancer helps to save patients through better medication and
treatment. Modern immuno oncology assay helps to detect early symptoms of the
cancer problem inside the human and helps to get better treatment.
The growing use of tobacco in different form as cigarettes,
e-cigarette and smokeless tobacco is the leading cause of the cancer problem.
Further, an unhealthy diet with low fruit and vegetable intake, lack of
physical exercise, excessive alcohol consumption is the other factors for the
growth of the immuno oncology assay market. As per the World Health Organisation,
the tobacco use is the single major factor for the cancer problem and it is
responsible for around 22% of cancer-related death globally.
North America is the leading region of the
immuno oncology assay market, owing to the presence of the large patient pool
in this region. Additionally, the availability of the several immuno oncology
assay service providing healthcare companies is helping to maintain the leading
position of this region in the global market. Europe is the second largest
market after North America for immuno oncology assay market. The
Asia-Pacific immuno oncology assay market is expected to grow at the highest
CAGR during the forecast period, owing to the government support and dedication
to pervade modern cancer treatment and testing facilities to its citizens at
the affordable cost.
The report on global immuno oncology assays market covers
segments such as product, technology, indication, and application. On the basis
of product, the sub-markets include consumables, and software. On the basis of
technology, the sub-markets include PCR, immunoassay, NGS, flow cytometry, and
other technology. On the basis of indication, the sub-markets include lung
cancer, colorectal cancer, melanoma, bladder cancer, and other indication. On
the basis of application, the sub-markets include research applications, and
The report provides profiles of the companies in the market
such as PerkinElmer, Inc., HTG Molecular Diagnostics, Inc., Foundation
Medicine, Inc., Sartorius AG, NanoString Technologies, Inc., Agilent
Technologies, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Illumina, Inc,
and QIAGEN GmbH.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of immuno oncology
assays market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.